SmithKline Beecham
Executive Summary
George Poste, PhD, to succeed retiring Keith Mansford, PhD, as chairman of Pharmaceuticals R&D beginning January 1992. Poste, 47, is an 11-year veteran of SmithKline; he is currently vice-chairman and VP-R&D....Genetics Institute: James Andress to board. Andress was formerly chairman of SmithKline Beecham plc and president and chief operating officer of Sterling Drug....